Circulating DNA demethylation-derived cytosine analytes as emerging biomarkers

Area of Science:

• Epigenetics and Molecular Biology
• Biomarker Discovery
• Translational Medicine

Background:

• DNA methylation and demethylation are key epigenetic processes regulating gene expression.
• Demethylation products, like 5-hydroxymethylcytosine (5hmC), are excreted into body fluids.
• These circulating cytosine analytes have potential as non-invasive biomarkers.

Purpose of the Study:

• To review the biological origins of circulating cytosine analytes.
• To discuss their clinical relevance in disease diagnosis and treatment monitoring.
• To explore technological challenges and future directions in detecting these epigenetic markers.

Main Methods:

• Review of existing literature on DNA demethylation and circulating epigenetic markers.
• Discussion of detection methods including high-throughput sequencing and mass spectrometry.
• Analysis of applications in cancer, neurological disorders, and treatment monitoring.

Main Results:

• Circulating cytosine analytes, including 5hmC, can be detected in body fluids.
• These analytes are linked to epigenetic regulation and cellular function.
• Emerging applications show potential in early disease detection and therapy assessment.

Conclusions:

• Circulating cytosine analytes represent a promising area for biomarker development.
• Technological advancements are crucial for accurate and efficient detection.
• Further research can drive progress in precision medicine through epigenetic insights.